1 |
Heigl F, Hettich R, Fassbender C, Klingel R, Mauch E, Durner J, Kern R, Kleiter I. Immunoadsorption as maintenance therapy for refractory neuromyelitis optica spectrum disorder. Ther Adv Neurol Disord 2023;16:17562864221150314. [PMID: 36762319 DOI: 10.1177/17562864221150314] [Reference Citation Analysis]
|
2 |
Liu T, Li L, Guo X, Li Q, Jia D, Ma L. Clinical analysis of neuromyelitis optica spectrum disease with area postrema syndrome as the initial symptom. Eur J Med Res 2022;27:315. [PMID: 36582004 DOI: 10.1186/s40001-022-00949-9] [Reference Citation Analysis]
|
3 |
Chen X, Wang Y, Dong P, Wang J, Yu X, Yu B. Efficacy of Combined Desensitization Therapy Based on Protein A Immunoadsorption on Anti-human Leukocyte Antigen Antibodies in Sensitized Kidney Transplant Recipients: A Retrospective Study. Cureus 2022. [DOI: 10.7759/cureus.28661] [Reference Citation Analysis]
|
4 |
Fu J, Wang Y, Li H, Zhou H, Song H, Sun M, Xu Q, Tan S, Wei S. Efficacy of Plasma Exchange Treatment for Demyelinating Optic Neuritis Associated with Various Serum Antibodies: A Prospective Cohort Study. Neurol Ther 2022. [PMID: 35397098 DOI: 10.1007/s40120-022-00344-w] [Reference Citation Analysis]
|
5 |
Li Q, Wang B, Cheng B, Liu C, Li N, Dai G, Xiao H, Zhou L, Zhangbao J, Wang L, Zhao C, Lu J, Quan C, Li F. Efficacy and safety of rehabilitation exercise in neuromyelitis optica spectrum disorder during the acute phase: a prospective cohort study. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103726] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|